[Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-resistant Prostate Cancer after Chemotherapy].

Richter, I; Dvorák, J; Hejzlarová, V; Chalupa, J; Sochor, M; Stankus, I; Barsová, L; Holikova, M; Forster, J; Bartos, J

[Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-resistant Prostate Cancer after Chemotherapy]. / Enzalutamid a abirateron v lécbe metastatického kastracne refrakterního karcinomu prostaty po predchozí chemoterapii.

Richter, I; Dvorák, J; Hejzlarová, V; Chalupa, J; Sochor, M; Stankus, I; Barsová, L; Holikova, M; Forster, J; Bartos, J.

Klin Onkol ; 29(2): 127-32, 2016.

Article in Cs | MEDLINE | ID: mdl-27081803

Subject(s)

Androstenes/therapeutic use; Antineoplastic Agents/therapeutic use; Phenylthiohydantoin/analogs & derivatives; Prostatic Neoplasms, Castration-Resistant/drug therapy; Aged; Aged, 80 and over; Benzamides; Humans; Male; Middle Aged; Neoplasm Metastasis; Nitriles; Phenylthiohydantoin/therapeutic use; Prostatic Neoplasms, Castration-Resistant/mortality; Prostatic Neoplasms, Castration-Resistant/pathology; Retrospective Studies

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Phenylthiohydantoin / Prostatic Neoplasms, Castration-Resistant / Androstenes / Antineoplastic Agents Type of study: Observational_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: Cs Journal: Klin Onkol Journal subject: NEOPLASIAS Year: 2016 Type: Article

Search on Google

XML

PubMed Links